Vellanki Avanish 4
4 · Rain Therapeutics Inc. · Filed Jun 2, 2022
Insider Transaction Report
Form 4
Vellanki Avanish
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2022-06-01$2.29/sh+25,000$57,250→ 2,471,627 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $2.285 to $2.3268. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.